Course Overview

Approximately 40% of human diseases may be attributable to defects in the cellular proteostasis machinery, including the ubiquitin-proteasome system. Accumulation of misfolded, damaged, or aggregated proteins can lead to prolonged stress, accumulation of reactive oxygen species, and cell death. In this webinar, brought to you by Bio-Techne, Jennifer Johnston will discuss how her research of ubiquitin-proteasome system elements, including Parkin E3 ligase, is used to diagnose and treat diseases caused by defects in proteostasis pathways.

Topics to be covered

  • The basics of the ubiquitin-proteasome system
  • The biology and druggability of ubiquitin E3 ligases
  • Modifications of ubiquitin proteins and their therapeutic and diagnostic applications

  • Wednesday, September 29, 2021
    2:30 - 3:30 PM Eastern Time


    Jennifer Johnston, PhD
    Cofounder and CEO

    Sponsored by



    TS_WEBINAR_Bio-Techne_TSU_Pioneering Research in E3 Ubiquitin Ligase Biology and Applications to Drug Discovery Sept 29, 2021_IO#403836

    You must have Javascript and Cookies enabled to access this webcast.

    Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.